UNSPSC 51182109: Desmopressin acetate anhydrous

This classification denotes an antidiurectic hormone analogue with the molecular formula C46H64N14O12S2.C2H4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1K12647SFC, chemically known as 1-(3-mercaptopropionic acid)-8-d-arginine-vasopressin monoacetate (salt), but more generally known as desmopressin acetate anhydrous, which bears US NIH Compound Identifier 64758.

European Medicines Agency schedules desmopressin acetate anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07001MIG. Most nations, for tariff purposes, schedule desmopressin acetate anhydrous under HS 29371900. SMILES: CC(=O)O.C1CCC(CC1)C[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSCCC(=O)N[C@H](C(=O)N2)CC3CCC(CC3)O)C(=O)N4CCC[C@H]4C(=O)N[C@H](CCCNC(=N)N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N.

UNSPSC 51182109 Desmopressin acetate anhydrous is a Commodity code covering a synthetic antidiuretic hormone used to treat diabetes insipidus, nocturnal enuresis, and hemophilia A — a pharmaceutical product that state and local governments procure through their health departments, state medicaid agencies, correctional health systems, and public hospital networks. The drug is typically purchased in bulk through competitive pharmaceutical bidding processes, cooperative purchasing agreements, or group purchasing organization (GPO) contracts that state health systems leverage to obtain volume discounts on specialized medications.

The source provided contains no recent state and local contract opportunities under this code. Without posted solicitations in the available record, the geographic distribution, issuing-body mix, and representative recent procurement activity cannot be characterized.